TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 8 | 0 | -1 | 6 | 18 | 17 | 14 | 9 |
S | %wins | 50 | 75 | 38 | 38 | 50 | 50 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/15/23 16:37 | 5/11/23 | TXG | 10X Genomics, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Mammen Mathai | CA | D | S.d | -1,743 | 52.82 | 0 | -33 | -16 | 170 | D | |||||||||||||||
2/19/14 19:13 | 2/14/14 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Mammen Mathai | CA | O | SVP,Rese | S | -1,378 | 39.36 | 33 | -35 | -16 | 187 | D | 124 | 83 | 13 | 14 | 13 | 8 | 12 | 5 | -1 | -1 | -15 | -31 | -28 | -51 |
8/1/13 17:33 | 7/30/13 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Mammen Mathai | CA | O | SVP,Rese | S | -256 | 36.51 | 33 | -7 | -3 | 212 | D | 74 | 29 | 74 | 15 | 9 | -10 | 0 | 5 | 1 | -4 | -5 | -2 | -1 | -30 |
5/2/13 19:06 | 4/30/13 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Mammen Mathai | CA | O | SVP,Rese | S | -236 | 33.74 | 33 | -7 | -3 | 206 | D | 17 | 55 | 31 | 52 | 43 | 44 | 4 | -1 | -1 | -8 | 2 | 13 | 10 | -22 |
2/22/13 19:03 | 2/20/13 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Mammen Mathai | CA | O | SVP,Rese | S | -155 | 22.14 | 28 | -7 | -3 | 213 | D | -9 | 16 | -18 | 4 | -5 | -4 | -1 | -3 | 0 | -6 | 5 | 68 | 68 | 82 |
11/6/12 19:01 | 11/2/12 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Mammen Mathai | CA | O | SVP,Rese | S | -150 | 21.45 | 9 | -7 | -3 | 206 | D | 7 | 1 | 9 | -21 | -18 | -13 | -10 | -3 | -4 | -3 | 3 | 5 | 45 | 70 |
8/15/12 19:05 | 8/13/12 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Mammen Mathai | CA | O | SVP,Rese | S | -643 | 25.74 | 22 | -25 | -11 | 212 | D | 76 | 32 | 46 | 22 | -3 | -11 | -4 | 1 | 1 | -1 | -4 | -25 | -18 | 35 |
2/23/11 19:11 | 2/18/11 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Mammen Mathai | CA | O | SVP,Rese | S | -86 | 23.12 | 15 | -4 | -1 | 249 | D | 52 | 108 | 59 | -5 | -13 | -1 | -13 | -9 | 2 | 7 | 10 | 19 | -20 | -16 |
9/2/10 19:09 | 9/1/10 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Mammen Mathai | CA | O | SVP,Rese | S | -57 | 12.84 | 7 | -4 | -4 | 118 | D | -4 | -15 | 7 | -12 | -3 | -16 | -2 | 2 | 4 | 7 | 53 | 93 | 78 | 45 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |